Q3 2023 13F Holders as of 9/30/2023
    
   
  
    
    
      
- 
        Type / Class
      
- 
        Equity / Common Stock
      
      
- 
        Shares outstanding
      
- 
        15.5M
      
      
- 
        Number of holders
      
- 
        130
      
      
- 
        Total 13F shares, excl. options
      
- 
        7.36M
      
      
- 
        Shares change
      
- 
        -13.1K
      
      
- 
        Total reported value, excl. options
      
- 
        $471M
      
      
- 
        Value change
      
- 
        -$558K
      
      
- 
        Number of buys
      
- 
        50
      
      
- 
        Number of sells
      
- 
        -64
      
      
- 
        Price
      
- 
        $63.98
      
 
     
   
 
  
    Significant Holders of NATIONAL HEALTHCARE CORP - Common Stock (NHC) as of Q3 2023
  
    
      143  filings reported holding NHC - NATIONAL HEALTHCARE CORP - Common Stock as of Q3 2023.
      
        NATIONAL HEALTHCARE CORP - Common Stock (NHC) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
        These institutions hold a total of 7.36M shares
          of 15.5M outstanding shares and own 47.43% of the company stock.
        
        Largest 10 shareholders include VANGUARD GROUP INC (1.33M shares), BlackRock Inc. (1M shares), DIMENSIONAL FUND ADVISORS LP (935K shares), RENAISSANCE TECHNOLOGIES LLC (428K shares), STATE STREET CORP (325K shares), GEODE CAPITAL MANAGEMENT, LLC (267K shares), GOLDMAN SACHS GROUP INC (209K shares), NORTHERN TRUST CORP (195K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (174K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (151K shares).
        
        This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
    
  
    
      
        
          | Investor | Option | Weight % | Change % | Value $ | * Price $ | Shares | Share Change | Activity | Report Period | 
      
      
      
    
   
  * Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
    An asterisk sign (*) next to the price indicates that the price is likely invalid.